SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 21.36-3.7%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David B. who wrote (1196)10/22/1997 12:22:00 PM
From: Ambrym Man  Read Replies (1) of 1693
 
Thanks,Joe and David.
I was satisfied with the results. In fact happy.
David you said >No mention by Quidel of the P&G comarketing effort<
The $2,539,000 (48%) increase in sales to US physicians is probably
a result of that effort. The Quidel salesmen (sorry Brooke, salespersons) are following up after the P&G sales visits. I do not
know how many salespersons Quidel has, but it is certainly not the 300
the P&G have out there pushing their H-pylori cure. The Quidel guys
have a lot of calls to make.
Also no mention of start-up in Mexico. I checked with our CFO and asked him where we would put that cost. His answer was that it would probably be in G&A, that way it would not affect our margins.
You will notice that G&A increased $355,000.
Revenues met my expectations. 2nd Q is historically a low quarter.
Dare we expect Q3 & Q4 to be 16 mil each. Earnings .09 each.
Although to meet analysts earnings expectations they would have to do
a little bit better than that. I am still long Quidel.
Anybody have the # for the conferance call.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext